Protagonist Therapeutics, Inc. (PTGX) Ownership

$51.05

$0.36 (0.71%)
Last update: 01:00 PM EST
Day's range
$49.91
Day's range
$51.37

Protagonist Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/02/2025 9.74 M $470.87 M   -1.50% 15.46%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2025 6.11 M $295.33 M   2.98% 9.70%
RTW INVESTMENTS, LP 05/15/2025 5.72 M $276.59 M   4.02% 9.08%
VANGUARD GROUP INC 05/09/2025 4.28 M $206.85 M   1.36% 6.79%
DEEP TRACK CAPITAL, LP 05/15/2025 3.00 M $145.08 M   200.00% 4.76%
STATE STREET CORP 05/15/2025 2.71 M $130.89 M   -18.75% 4.30%
BVF INC/IL 05/15/2025 2.58 M $124.53 M   35.53% 4.09%
JOHNSON & JOHNSON 05/07/2025 2.45 M $118.44 M   0.00% 3.89%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.42 M $68.86 M   3.38% 2.26%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 1.32 M $63.93 M   -5.07% 2.10%
PERCEPTIVE ADVISORS LLC 05/15/2025 1.09 M $52.77 M   -14.19% 1.73%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 987.37 K $47.75 M   5.03% 1.57%
ADAR1 CAPITAL MANAGEMENT, LLC 05/15/2025 939.67 K $45.44 M   -7.91% 1.49%
WOODLINE PARTNERS LP 05/15/2025 897.70 K $43.41 M   54.16% 1.43%
INVESCO LTD. 05/12/2025 859.65 K $41.57 M   16.33% 1.37%
LYNX1 CAPITAL MANAGEMENT LP 05/15/2025 733.01 K $35.45 M   100.00% 1.16%
AMERICAN CENTURY COMPANIES INC 05/13/2025 685.82 K $33.17 M   -26.12% 1.09%
NORTHERN TRUST CORP 05/13/2025 639.51 K $30.93 M   1.74% 1.02%
JEFFERIES FINANCIAL GROUP INC. 05/08/2025 631.89 K $30.56 M   -57.58% 1.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 557.72 K $26.97 M   -3.58% 0.89%
GOLDMAN SACHS GROUP INC 06/27/2025 555.55 K $26.87 M   -26.78% 0.88%
EVERSEPT PARTNERS, LP 05/15/2025 547.12 K $26.46 M   -19.40% 0.87%
683 CAPITAL MANAGEMENT, LLC 05/15/2025 500.00 K $24.18 M   21.95% 0.79%
MORGAN STANLEY 05/15/2025 497.11 K $24.04 M   -8.00% 0.79%
FMR LLC 05/12/2025 478.34 K $23.13 M   8.10% 0.76%
BANK OF AMERICA CORP /DE/ 05/15/2025 471.75 K $22.81 M   249.77% 0.75%
JPMORGAN CHASE & CO 05/12/2025 468.90 K $22.68 M   -18.73% 0.74%
TORONTO DOMINION BANK 05/15/2025 445.44 K $21.54 M   30.64% 0.71%
COLONY GROUP, LLC 05/20/2025 435.10 K $21.04 M   2.24% 0.69%
AFFINITY ASSET ADVISORS, LLC 05/14/2025 400.00 K $19.34 M   207.69% 0.64%
MANGROVE PARTNERS 05/15/2025 395.38 K $19.12 M   0.00% 0.63%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 05/14/2025 379.65 K $18.36 M   201.55% 0.60%
BANK OF NEW YORK MELLON CORP 04/29/2025 376.86 K $18.23 M   -3.56% 0.60%
UBS GROUP AG 05/13/2025 352.87 K $17.06 M   166.10% 0.56%
NEW VERNON CAPITAL HOLDINGS II LLC 05/15/2025 348.10 K $7.20 M   11,271.94% 0.55%
PRINCIPAL FINANCIAL GROUP INC 04/28/2025 347.10 K $16.79 M   2.75% 0.55%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 343.50 K $16.61 M   100.00% 0.55%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 343.41 K $16.61 M   9.96% 0.55%
ARTIA GLOBAL PARTNERS LP 05/15/2025 333.85 K $16.15 M   13.61% 0.53%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 323.57 K $15.65 M   46.30% 0.51%
RAYMOND JAMES FINANCIAL INC 05/13/2025 298.83 K $14.45 M   -1.48% 0.47%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 295.59 K $14.29 M   -0.31% 0.47%
CAPTION MANAGEMENT, LLC 05/15/2025 288.60 K $13.96 M   100.00% 0.46%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2025 287.30 K $13.89 M   100.00% 0.46%
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 05/07/2025 248.95 K $12.04 M   -19.86% 0.40%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2025 235.07 K $11.37 M   -30.80% 0.37%
UBS ASSET MANAGEMENT AMERICAS INC 05/19/2025 208.76 K $10.10 M   -27.49% 0.33%
BURNEY CO/ 05/06/2025 201.99 K $9.77 M   100.00% 0.32%
CAPTION MANAGEMENT, LLC 05/15/2025 193.90 K $9.38 M   117.38% 0.31%
JANE STREET GROUP, LLC 05/19/2025 193.30 K $9.35 M   214.05% 0.31%

Protagonist Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 326 institutional investors and hedge funds held shares of Protagonist Therapeutics, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 9.74 M

FARALLON CAPITAL MANAGEMENT LLC: 6.11 M

RTW INVESTMENTS, LP: 5.72 M

VANGUARD GROUP INC: 4.28 M

Deep Track Capital, LP: 3 M

STATE STREET CORP: 2.71 M

103.67% of Protagonist Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 76.20 M shares in the last 24 months. This purchase volume represents approximately $3.89 B in transactions.